Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Pharmacology ; 57(3): 160-72, 1998 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-9691236

RESUMEN

The activities of 8 platinum drug complex salts were determined against Leishmania donovani promastigotes. The three most active salts were selected: [PtIVBr6]H2 (pentamidine); [PtIVBr6]H2 (stilbamidine), and [PtIVCl6]H2 (2-piperazinyl(1) ethyl amine), which induced growth-inhibition rates of more than 50% at 24 h of treatment and at the maximum dosage tested. The cytotoxicity assays on the macrophage cell line J-774 showed high cytotoxicity for the salt [PtIVBr6]H2 (stilbamidine) with a percentage of specific 51Cr release of 58.2% at 24 h of incubation and 100 microg/ml. Meanwhile, assays of the other compounds showed practically no cytotoxicity. The salt [PtIVBr6]H2 (pentamidine) notably inhibited the incorporation of 3H-thymidine in the treated parasites. The ultrastructural alterations observed in the flagellates treated with the salts [PtIVCl6]H2 (2-piperazinyl(1)ethyl amine) and [PtIVBr6]H2 (pentamidine) suggest that both act preferentially at the nuclear level and at the kinetoplast-mitochondrion complex. Both compounds showed a high in vivo activity in parasitized Wistar rats.


Asunto(s)
Antiprotozoarios/farmacología , Leishmania donovani/efectos de los fármacos , Compuestos de Platino/farmacología , Animales , Antiprotozoarios/uso terapéutico , Antiprotozoarios/toxicidad , Línea Celular , Cricetinae , Evaluación Preclínica de Medicamentos , Humanos , Leishmania donovani/ultraestructura , Leishmaniasis Visceral/tratamiento farmacológico , Mesocricetus , Ratones , Ratones Endogámicos BALB C , Pentamidina/farmacología , Pentamidina/uso terapéutico , Pentamidina/toxicidad , Compuestos de Platino/uso terapéutico , Compuestos de Platino/toxicidad , Ratas , Ratas Wistar , Estilbamidinas/farmacología , Estilbamidinas/uso terapéutico , Estilbamidinas/toxicidad
2.
J Antimicrob Chemother ; 40(1): 47-57, 1997 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-9249204

RESUMEN

The action of 16 newly synthesized metal complexes having the general structure cis-Pt-(II)-Xn-Ln have been tested in vitro against the promastigote forms of Leishmania donovani. The metal complexes at 24 h and maximum dosages inhibited growth from 0%, e.g. in cis-Pt-nifurtimox, to 100%, e.g. in cis-Pt-(2,3,4,5,6-pentafluoroaniline)2Br2 or cis-Pt-pentamidine-I2. A study of the cytotoxicty of these latter complexes on the phagocytic cell line J-774 showed neither high cytotoxicity nor cytolysis. At the maximum dosage after 24 h of permanent contact with the cells (extreme, non-physiological conditions), cytolysis did not exceed 30%. For most of the compounds, cytolysis ranged from 0%, for cis-Pt-oxamniquine-Cl2 to 27.7%, for cis-Pt-pentamidine-I2. The compound cis-Pt-(2,3,4,5,6-pentafluoroaniline)2-Br2 caused up to 1.4% cytolysis under the above conditions. Parasites exposed to cis-Pt-pentamidine-I2 showed notably reduced DNA, RNA and protein synthesis, unlike those exposed to other compounds. Parasites examined by electron microscopy showed effects mainly on the nucleus, though in some cases the mitochondria were affected, altering the internal membranes of the cytoplasmic organelles. The in-vivo activity of the complex cis-Pt-guanethidine-Cl2 was evaluated in parasitized Wistar rats, in which the number of amastigotes per gram of spleen was reduced by 75% compared with controls.


Asunto(s)
Guanetidina/análogos & derivados , Leishmania donovani/efectos de los fármacos , Compuestos Organometálicos/farmacología , Compuestos Organoplatinos/farmacología , Animales , Cromatina/efectos de los fármacos , Cromatina/ultraestructura , Cricetinae , ADN Protozoario/biosíntesis , ADN Protozoario/efectos de los fármacos , Evaluación Preclínica de Medicamentos/métodos , Guanetidina/farmacología , Leishmania donovani/crecimiento & desarrollo , Leishmania donovani/ultraestructura , Leishmaniasis Visceral/tratamiento farmacológico , Macrófagos/efectos de los fármacos , Macrófagos/parasitología , Ratones , Mitocondrias/efectos de los fármacos , Mitocondrias/ultraestructura , Nifurtimox/metabolismo , Nifurtimox/farmacología , Oxamniquina/análogos & derivados , Oxamniquina/metabolismo , ARN Protozoario/biosíntesis , ARN Protozoario/efectos de los fármacos , Ratas , Ratas Wistar , Bazo/efectos de los fármacos , Bazo/parasitología , Relación Estructura-Actividad , Pruebas de Toxicidad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA